| Filed On | Filing |
|---|---|
| 08 Oct 2026 |
Form 4: Torley Helen, Director
Received 20,000 shares by exercise or conversion ($368K) · Sold 20,000 shares ($2.19M) · Received 20,000 shares by exercise or conversion ($368K) · 3 more |
| 02 Oct 2026 |
Form 4: Daly James M, Director
Received 1,169 shares as a grant or award · Granted 1,775 Option to Purchase Common Stock |
| 02 Oct 2026 |
Form 4: Posard Matthew L., Director
Sold 5,230 shares ($568K) |
| 17 Sep 2026 |
Form 4: Posard Matthew L., Director
Sold 18,996 shares ($2.05M) |
| 11 Sep 2026 |
Form 4: Torley Helen, Director
Received 20,000 shares by exercise or conversion ($368K) · Sold 20,000 shares ($2.15M) · Received 20,000 shares by exercise or conversion ($368K) · 3 more |
| 02 Sep 2026 |
Form 4: Appelhans Dannielle, Director
Received 1,161 shares as a grant or award · Granted 1,778 Option to Purchase Common Stock |
| 19 Aug 2026 |
Form 4: Torley Helen, Director
Received 20,000 shares by exercise or conversion ($368K) · Sold 20,000 shares ($2.05M) · Received 20,000 shares by exercise or conversion ($368K) · 3 more |
| 11 Aug 2026 |
Form 4: Connaughton Bernadette, Director
Sold 1,626 shares ($167K) |
| 09 Jul 2026 |
Form 4: Torley Helen, Director
Received 1,923 shares by exercise or conversion ($23.2K) · Sold 1,923 shares ($153K) |
| 02 Jul 2026 |
Form 4: Ramsay David A, EVP, PRESIDENT, DRUG DELIVERY
Received 10,000 shares by exercise or conversion · Gave up 5,408 shares to cover exercise price or tax ($423K) · Granted 16,232 Restricted Stock Units · 1 more |
| 02 Jul 2026 |
Form 4: Connaughton Bernadette, Director
Sold 1,625 shares ($125K) |
| 02 Jul 2026 |
Form 4: Snellgrove Darren, SVP, Chief Financial Officer
Granted 41,554 Restricted Stock Units · Granted 127,432 Option to Purchase Common Stock |
| 30 Jun 2026 |
Form 4: Krishnan Mahesh, Director
Received 7,304 shares by exercise or conversion ($281K) · Sold 7,304 shares ($548K) |
| 15 Jun 2026 |
Form 4: Snyder Mark Howard, SVP, CHIEF LEGAL OFFICER
Received 5,034 shares by exercise or conversion · Gave up 2,715 shares to cover exercise price or tax ($189K) |
| 03 Jun 2026 |
Form 4: Torley Helen, Director
Received 20,000 shares by exercise or conversion ($241K) · Sold 20,000 shares ($1.35M) · Received 20,000 shares by exercise or conversion ($241K) · 3 more |
| 02 Jun 2026 |
Form 4: Connaughton Bernadette, Director
Sold 1,625 shares ($108K) |
| 13 May 2026 |
Form 4: Torley Helen, Director
Received 20,000 shares by exercise or conversion ($241K) · Sold 20,000 shares ($1.31M) · Received 20,000 shares by exercise or conversion ($241K) · 3 more |
| 07 May 2026 |
Form 4: Posard Matthew L., Director
Received 3,796 shares as a grant or award · Granted 6,040 Option to Purchase Common Stock |
| 07 May 2026 |
Form 4: Krishnan Mahesh, Director
Received 3,796 shares as a grant or award · Granted 6,040 Option to Purchase Common Stock |
| 07 May 2026 |
Form 4: Lang James Paul, Director
Received 3,796 shares as a grant or award · Granted 6,040 Option to Purchase Common Stock |
Loading...